RESUMEN
To compare hospital mortality and postoperative complications in patients with severe coronary artery disease undergoing coronary artery bypass grafting with or without coronary endarterectomy, 100 consecutive patients were divided into 2 groups of 50 patients each. Group 1 had coronary endarterectomy, and group 2 had no coronary endarterectomy. There were 87 men and 13 women, with a mean age of 54.79 +/-7.8 years; 48% had stable angina. The right coronary artery was endarterectomized in 22 patients, the left anterior descending artery in 21, and the left circumflex in 7. There were no significant differences in outcomes. There was 1 hospital death in each group. Perioperative myocardial infarction occurred in 2 patients in group 1 and 1 in group 2. Endarterectomy is a suitable option to achieve complete revascularization in patients with refractory angina and severe diffuse disease.
Asunto(s)
Puente de Arteria Coronaria/mortalidad , Enfermedad de la Arteria Coronaria/mortalidad , Enfermedad de la Arteria Coronaria/cirugía , Endarterectomía/mortalidad , Mortalidad Hospitalaria , Angina de Pecho/mortalidad , Angina de Pecho/cirugía , Femenino , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Infarto del Miocardio/mortalidad , Infarto del Miocardio/cirugía , Complicaciones Posoperatorias/mortalidad , Estudios Prospectivos , Ensayos Clínicos Controlados Aleatorios como Asunto , Factores de RiesgoRESUMEN
To assess long-term survival and anticoagulant-related complications after mechanical valve replacement in adolescents with rheumatic heart disease, 88 patients aged Asunto(s)
Anticoagulantes/uso terapéutico
, Enfermedades de las Válvulas Cardíacas/cirugía
, Implantación de Prótesis de Válvulas Cardíacas
, Cardiopatía Reumática/cirugía
, Adolescente
, Anticoagulantes/efectos adversos
, Niño
, Femenino
, Estudios de Seguimiento
, Enfermedades de las Válvulas Cardíacas/mortalidad
, Prótesis Valvulares Cardíacas
, Implantación de Prótesis de Válvulas Cardíacas/efectos adversos
, Implantación de Prótesis de Válvulas Cardíacas/instrumentación
, Hemorragia/inducido químicamente
, Mortalidad Hospitalaria
, Humanos
, Estimación de Kaplan-Meier
, Masculino
, Estudios Prospectivos
, Diseño de Prótesis
, Cardiopatía Reumática/mortalidad
, Accidente Cerebrovascular/etiología
, Accidente Cerebrovascular/mortalidad
, Accidente Cerebrovascular/prevención & control
, Trombosis/etiología
, Trombosis/mortalidad
, Trombosis/prevención & control
, Factores de Tiempo
, Resultado del Tratamiento
RESUMEN
Anticoagulation in pregnancy was evaluated in 33 women with a mechanical heart valve prosthesis who had 53 pregnancies between 1994 and 2006. Their mean age at valve operation was 24.4 +/- 5.4 years, and 22 (67%) had isolated mitral valve disease. Of these patients, 22 had a single pregnancy, 5 had 2 pregnancies, 3 had 3, and 3 had 4. In 43 pregnancies, the patients took warfarin throughout; in the other 10, heparin was used in the first trimester followed by warfarin until the last 15 days. Mean international normalized ratio and warfarin levels before, during, and after pregnancy were similar. Complications occurred in 3 (6%) women who had thrombosed valves: 2 (20%) in the heparin group and 1 (2%) who had warfarin only. Live births resulted from 37 (70%) pregnancies. There were significantly more abortions in the heparin group (6; 60%) than the warfarin group (8; 19%). Hemorrhage requiring transfusion occurred in 2 (5%) patients in the warfarin group. All live births resulted in healthy babies. It was concluded that anticoagulation with warfarin is safe during pregnancy in women with mechanical heart valves.
Asunto(s)
Anticoagulantes/uso terapéutico , Implantación de Prótesis de Válvulas Cardíacas/efectos adversos , Heparina/uso terapéutico , Complicaciones Cardiovasculares del Embarazo/prevención & control , Trombosis/prevención & control , Warfarina/uso terapéutico , Aborto Espontáneo/inducido químicamente , Administración Oral , Adulto , Anticoagulantes/administración & dosificación , Anticoagulantes/efectos adversos , Esquema de Medicación , Femenino , Prótesis Valvulares Cardíacas , Implantación de Prótesis de Válvulas Cardíacas/instrumentación , Hemorragia/inducido químicamente , Heparina/administración & dosificación , Heparina/efectos adversos , Humanos , Pakistán , Selección de Paciente , Guías de Práctica Clínica como Asunto , Embarazo , Estudios Prospectivos , Diseño de Prótesis , Medición de Riesgo , Trombosis/etiología , Factores de Tiempo , Resultado del Tratamiento , Warfarina/administración & dosificación , Warfarina/efectos adversosRESUMEN
Household poisons can cause serious damage to the health of children. Turpentine oil, used chiefly as a solvent in paints, varnishes, and waxes; is often placed within easy reach of children during polishing or painting work. It is capable of causing serious toxicity, whether ingested or inhaled. Pulmonary aspiration can lead to lung parenchymal damage and turpentine-associated pneumonia. We report a case of exploratory ingestion and inhalation of turpentine oil in an 18-month-old boy, leading to extensive lung parenchymal damage, formation of multiple abscess cavities, and necrosis treated with decortication and segmental resection.
